David Michael Johnson, Director at Aura Biosciences, Inc. (AURA), bought 40,000 shares at $13.99 ($573K) on 2022-06-13, disclosed to the SEC on 2022-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.04 | 3,000 | $45K | 7.9% |
| 2 | $15.04 | 10,000 | $150K | 26.2% |
| 3 | $13.99 | 7,000 | $98K | 17.1% |
| 4 | $13.99 | 20,000 | $280K | 48.8% |
| Total | $14.33 avg | 40,000 | $573K | 100% |
| Filing → |
| AURA | BUY | 2023-11-09 | $1.1M | — | Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2023-01-09 | $21K | — | Filing → |